We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
107 hedge funds and large institutions have $71.2M invested in Lineage Cell Therapeutics in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
12% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 26
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.45% less ownership
Funds ownership: 43.87% → 43.42% (-0.45%)
7% less call options, than puts
Call options by funds: $40K | Put options by funds: $43K
9% less funds holding
Funds holding: 118 → 107 (-11)
17% less capital invested
Capital invested by funds: $85.9M → $71.2M (-$14.7M)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
Holders
107
Holders Change
-11
Holders Change %
-9.32%
% of All Funds
2.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
11
Increased
29
Reduced
26
Closed
19
Calls
$40K
Puts
$43K
Net Calls
-$3K
Net Calls Change
-$18K
